CHELSIE PETRIE: Open Payments
NPI 1083385934 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,697 in 116 payments from 27 companies in 2025. Trend: 2023 $16 · 2024 $1,823 · 2025 $5,697
Speaker / faculty: $3,500Food & beverage: $2,197
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. | 12 | $3,577 |
| Amgen Inc. | 16 | $282 |
| Xeris Pharmaceuticals, Inc. | 12 | $217 |
| Madrigal Pharmaceuticals | 7 | $205 |
| SANOFI-AVENTIS U.S. LLC | 9 | $177 |
| Novo Nordisk Inc | 7 | $155 |
| Corcept Therapeutics | 8 | $146 |
| BETA BIONICS, INC. | 9 | $145 |
| Lilly USA, LLC | 6 | $114 |
| Dexcom, Inc. | 4 | $78 |
Products named: t:slim X2 Insulin Pump with Control-IQ, REZDIFFRA, TEPEZZA, TZIELD, Korlym, iLet Bionic Pancreas, GVOKE HYPOPEN, MOUNJARO.
Industry payments across OK — which companies pay providers there.
